Drug Industry – Page 15

Delaware Court Ruling Allows Zantac Lawsuits to Proceed, GSK Market Cap Plummets by Over $8 Billion

12 months ago talkbio0Tagged Caps, court, Delaware, Drug Industry, financial impact, legal battles, Market, SmithKline Beecham, Zantac lawsuits

Zantac lawsuits, GSK market cap, Delaware court, pharmaceutical industry, legal battles, financial impact

James Sabry Departs Roche After 14 Years, Returns to Biotech Industry

12 months ago talkbio0Tagged biotech, career, Drug Industry, genentech, James, Partnering, Roche (company), Sabry

James Sabry, Roche, Genentech, Biotech, Partnering, Pharmaceutical Industry, Career Moves

Eli Lilly Invests $5.3 Billion to Boost Production of Mounjaro and Zepbound

12 months ago12 months ago talkbio0Tagged Diabetes, Drug Industry, eli lilly, Investments, Manufacture, Mounjaro, Obesity, Weight Loss, Zepbound

** Eli Lilly, Mounjaro, Zepbound, Manufacturing, Investment, Diabetes, Obesity, Weight Loss, Pharmaceutical Industry

Pfizer’s Continuous Cost-Cutting: A $4B Savings Drive Extended to 2027

12 months ago talkbio0Tagged cost-cutting, Drug Industry, Efficiency, Financial savings, Pfizer, profitability, restructuring

Pfizer, cost-cutting, savings drive, 2027, pharmaceutical industry, restructuring, efficiency, profitability.

Exscientia Streamlines Operations, Prioritizes AI-Driven Drug Discovery

12 months ago talkbio0Tagged AI-generated pipeline, Biotechnology, Drug Discovery, Drug Industry, Efficiency, Exscientia, operational, Staff

Exscientia, AI-generated pipeline, drug discovery, staff reduction, operational efficiency, biotechnology, pharmaceutical industry

Sen. Wyden Scrutinizes Pfizer’s Tax Rate Amidst Ongoing Investigation

12 months ago talkbio0Tagged Avoidance, Corporate, Drug Industry, Evaluation, financial transparency, Pfizer, Rating (action), Taxation, Wyden

Sen. Wyden, Pfizer, tax rate, investigation, corporate taxation, tax avoidance, pharmaceutical industry, financial transparency

AstraZeneca’s Billion-Dollar Bet: Accelerating Biopharma Innovation in China

12 months ago talkbio0Tagged AstraZeneca, Biopharma, China sales, Clinical Trials, Collaboration, development aspects, Drug Industry, Health care facility, innovation, Investments, partnerships, research

AstraZeneca, China sales, biopharma innovation, investment, research and development, healthcare market, pharmaceutical industry, clinical trials, partnerships, collaborations.

Exscientia, AI Biotech Firm, Announces Workforce Reduction Amidst Pipeline Changes and CEO Departure

12 months ago talkbio0Tagged AI, Artificial Intelligence, CEO, Drug Discovery, Drug Industry, Exscientia, firing, restructuring

Exscientia, AI biotech, workforce reduction, pipeline cut, CEO firing, restructuring, pharmaceutical industry, drug discovery

AstraZeneca’s Ambitious Vision: Pursuing $80 Billion in Revenue and 20 New Drugs by 2030

12 months ago talkbio0Tagged AstraZeneca, Biotechnology, Drug Development, Drug Industry, expansion, growth strategy, healthcare innovation, Market

AstraZeneca, revenue target, new drugs, 2030, growth strategy, pharmaceutical industry, healthcare innovation, biotechnology, drug development, market expansion.

AstraZeneca Targets $80 Billion in Revenue by 2030: A Rapid Growth Trajectory

12 months ago talkbio0Tagged 2030, AstraZeneca, Drug Development, Drug Industry, growth trajectory, healthcare solutions

AstraZeneca, revenue target, 2030, growth trajectory, pharmaceutical industry, drug development, healthcare solutions.